Secondary exploratory analysis of four placebo-controlled crossover RCTs of ketamine (39 inpatients with MDD, 44 with bipolar depression): higher baseline TSH was associated with greater drops in depression and anhedonia after ketamine in bipolar depression, not in MDD.
Secondary analysisn = 83
Greene et al. Thyroid-stimulating hormone is associated with differential antidepressant and anti-anhedonic response to ketamine in bipolar depression but not major depressive disorder